康達新材(002669.SZ)擬51萬元與關聯方陸企亭共設孵化器公司
格隆匯1月2日丨康達新材(002669.SZ)公佈,公司於2019年12月30日召開了第四屆董事會第十六次會議、第四屆監事會第十二次會議審議通過了《關於與關聯方共同對外投資設立合資公司暨關聯交易的議案》。公司擬使用自有資金51萬元與關聯方陸企亭共同出資設立杭州灣(上海)康達新材料孵化器有限公司(“合資公司”,暫定名,最終以工商登記核准名稱為準)。
公司此次對外投資是為了吸引創新性新材料項目落地孵化,促進科學技術成果的轉化,拓展公司業務佈局。與關聯方陸企亭先生共同對外投資,一方面可以充分發揮陸企亭先生在行業內的影響力,另外一方面可以將公司的技術、人才、市場、資本優勢轉化為服務優勢,有利於實現公司與孵化企業的業務協同和價值共享。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.